Cargando…
Editorial: Immunotherapy for NSCLC with oncogenic driver variants
| Autores principales: | , , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Frontiers Media S.A.
2022
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9775290/ https://www.ncbi.nlm.nih.gov/pubmed/36568249 http://dx.doi.org/10.3389/fonc.2022.1095947 |
| _version_ | 1784855608037474304 |
|---|---|
| author | Du, Yijia Chu, Qian Lou, Yanyan He, Yong Hu, Hongbo Hu, Qipeng Huang, Meijuan |
| author_facet | Du, Yijia Chu, Qian Lou, Yanyan He, Yong Hu, Hongbo Hu, Qipeng Huang, Meijuan |
| author_sort | Du, Yijia |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-9775290 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2022 |
| publisher | Frontiers Media S.A. |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-97752902022-12-23 Editorial: Immunotherapy for NSCLC with oncogenic driver variants Du, Yijia Chu, Qian Lou, Yanyan He, Yong Hu, Hongbo Hu, Qipeng Huang, Meijuan Front Oncol Oncology Frontiers Media S.A. 2022-12-08 /pmc/articles/PMC9775290/ /pubmed/36568249 http://dx.doi.org/10.3389/fonc.2022.1095947 Text en Copyright © 2022 Du, Chu, Lou, He, Hu, Hu and Huang https://creativecommons.org/licenses/by/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms. |
| spellingShingle | Oncology Du, Yijia Chu, Qian Lou, Yanyan He, Yong Hu, Hongbo Hu, Qipeng Huang, Meijuan Editorial: Immunotherapy for NSCLC with oncogenic driver variants |
| title | Editorial: Immunotherapy for NSCLC with oncogenic driver variants |
| title_full | Editorial: Immunotherapy for NSCLC with oncogenic driver variants |
| title_fullStr | Editorial: Immunotherapy for NSCLC with oncogenic driver variants |
| title_full_unstemmed | Editorial: Immunotherapy for NSCLC with oncogenic driver variants |
| title_short | Editorial: Immunotherapy for NSCLC with oncogenic driver variants |
| title_sort | editorial: immunotherapy for nsclc with oncogenic driver variants |
| topic | Oncology |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9775290/ https://www.ncbi.nlm.nih.gov/pubmed/36568249 http://dx.doi.org/10.3389/fonc.2022.1095947 |
| work_keys_str_mv | AT duyijia editorialimmunotherapyfornsclcwithoncogenicdrivervariants AT chuqian editorialimmunotherapyfornsclcwithoncogenicdrivervariants AT louyanyan editorialimmunotherapyfornsclcwithoncogenicdrivervariants AT heyong editorialimmunotherapyfornsclcwithoncogenicdrivervariants AT huhongbo editorialimmunotherapyfornsclcwithoncogenicdrivervariants AT huqipeng editorialimmunotherapyfornsclcwithoncogenicdrivervariants AT huangmeijuan editorialimmunotherapyfornsclcwithoncogenicdrivervariants |